Skip to main content

Align Technology stock price and financials

  • ALGN · Nasdaq
  • Medical devices
  • Health Care Supplies
  • S&P 500
$168.32+0.81%Close 13 Nov 2026
Market value
$11.84B
P/E
24.06
EV / EBITDA
12.70
Beta · 1 year
1.31
Return · 1 year
+18.8%
52-week range$130.23 — $200.44

Share price close 16 Nov 2026

+12.2%1 monthHigh $174.26Low $147.31
$140$150$160$170$180Q3 FY2026 report filed 4 Nov 202623 Oct29 Oct4 Nov10 Nov16 Nov
+6.5%6 monthsHigh $188.39Low $139.87
$120$140$160$180$200Q2 FY2026 report filed 5 Aug 2026Q3 FY2026 report filed 4 Nov 20264 Jun2 Jul30 Jul26 Aug23 Sep20 Oct16 Nov
+7.3%year to dateHigh $197.51Low $139.87
$120$140$160$180$200Q4 FY2025 report filed 27 Feb 2026Q1 FY2026 report filed 6 May 2026Q2 FY2026 report filed 5 Aug 2026Q3 FY2026 report filed 4 Nov 202611 Feb30 Mar14 May1 Jul17 Aug1 Oct16 Nov
+22.1%1 yearHigh $197.51Low $132.28
$120$140$160$180$200Q4 FY2025 report filed 27 Feb 2026Q1 FY2026 report filed 6 May 2026Q2 FY2026 report filed 5 Aug 2026Q3 FY2026 report filed 4 Nov 2026Jan 26Mar 26Apr 26Jun 26Aug 26Sep 26Nov 26
−18.3%3 yearsHigh $330.25Low $124.88
$100$200$300$400Q4 FY2023 report filed 28 Feb 2024Q1 FY2024 report filed 3 May 2024Q2 FY2024 report filed 2 Aug 2024Q3 FY2024 report filed 5 Nov 2024Q4 FY2024 report filed 28 Feb 2025Q1 FY2025 report filed 8 May 2025Q2 FY2025 report filed 6 Aug 2025Q3 FY2025 report filed 5 Nov 2025Q4 FY2025 report filed 27 Feb 2026Q1 FY2026 report filed 6 May 2026Q2 FY2026 report filed 5 Aug 2026Q3 FY2026 report filed 4 Nov 2026Apr 24Sep 24Feb 25Aug 25Jan 26Jun 26Nov 26
+76.6%10 yearsHigh $725.24Low $90.93
$0$200$400$600$800Apr 18Sep 19Feb 21Jul 22Jan 24Jun 25Nov 26

Quarterly or annual report filed

In one paragraph

Align Technology reported revenue of $4.03 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), up 0.9% from fiscal 2024. Net income was $410 million and diluted earnings per share $5.65.

In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 30 Sep 2026), revenue was $1.01 billion, up 1.9% from a year earlier.

Figures from Align Technology's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 4 Nov 2026.

Against Health Care

Growth
Upper half
Revenue +10.3% a year over five years · 14th of 37
Profitability
Upper half
Return on invested capital 11.5%, five-year average · 17th of 38
Balance sheet
Top quarter
More cash than debt · 6th of 38
Valuation
Below the median
P/E 24.1 · 11th of 36

Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.

Revenue FY2025
$4.03B+0.9%
Net income
$410.4M−2.6%
Diluted EPS
$5.65+0.5%
Gross margin
67.2%−2.8 pts
Free cash flow
$490.8M−21.2%
Net cash
$980.5M

Fiscal 2025 against fiscal 2024; bars show the last 10 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.

Revenue and net income fiscal 2016–2025

  • Revenue
  • Net income
$0$1B$2B$3B$4B$5BRevenue, FY16: $1.08BNet income, FY16: $189.68MFY16Revenue, FY17: $1.47BNet income, FY17: $231.42MFY17Revenue, FY18: $1.97BNet income, FY18: $400.24MFY18Revenue, FY19: $2.41BNet income, FY19: $442.78MFY19Revenue, FY20: $2.47BNet income, FY20: $1.78BFY20Revenue, FY21: $3.95BNet income, FY21: $772.02MFY21Revenue, FY22: $3.73BNet income, FY22: $361.57MFY22Revenue, FY23: $3.86BNet income, FY23: $445.05MFY23Revenue, FY24: $4BNet income, FY24: $421.36MFY24Revenue, FY25: $4.03BNet income, FY25: $410.35MFY25

Latest quarter · Q3 FY2026 to 30 Sep 2026, filed 4 Nov 2026 · Full results →

Revenue
$1.01B+1.9% on a year
Gross margin
68.7%+4.5 pts on a year
Operating income
$169.2M+75.7% on a year
Net income
$135.0M+138% on a year
Diluted EPS
$1.90+144% on a year
Free cash flow
$137.9M−18.4% on a year

Comparable companies All of Health Care →

Align Technology beside the other S&P 500 members in Health Care Supplies, then the largest in Health Care, by market value.

Align Technology and comparable companies
CompanyMarket valueDay1 yearRevenue growthNet marginP/E
Align TechnologyALGN$11.84B+0.8%+18.8%+4.4%11.8%24.1
The Cooper CompaniesCOO$11.91B+0.7%−13.6%+4.7%13.5%20.9
West Pharmaceutical ServicesWST—+1.2%+52.1%———
Eli LillyLLY$1.37T+1.1%+41.8%+45.5%31.9%49.6
Johnson & JohnsonJNJ$686.1B+0.8%+47.0%+7.8%16.2%42.6
AbbVieABBV$525.9B+0.2%+26.5%+10.7%15.7%51.1
AmgenAMGN$253.8B−0.3%+38.5%+8.2%24.1%27.0

Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.

Margins fiscal 2016–2025

  • Gross
  • Operating
  • Net
0%50%100%67.2%13.5%10.2%FY16FY19FY22FY25

Align Technology revenue by segment, product and region

Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.

By segment

Align Technology revenue by segment, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
Clear Aligner$3.25B$3.07B−5.4%$3.20B+4.1%$3.23B+1.0%$3.25B+0.5%
Systems and Services$705.5M$662.0M−6.2%$662.9M+0.1%$768.9M+16.0%$789.6M+2.7%
Total revenue$3.95B$3.73B$3.86B$4.00B$4.04B

By country

Align Technology revenue by country, by fiscal year
RevenueFY 2021FY 2022FY 2023FY 2024FY 2025
United States$1.72B$1.66B−3.7%$1.67B+0.4%$1.70B+1.8%$1.66B−2.0%
Other International$875.1M$858.5M−1.9%$1.03B+19.7%$1.32B+28.4%$1.45B+10.1%
CH$1.35B$1.22B−10.1%$1.17B−3.9%$983.6M−15.8%$920.6M−6.4%
Total revenue$3.95B$3.73B$3.86B$4.00B$4.04B

Financial statements

Fiscal years, the latest ending 31 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.

Income statement

Align Technology income statement, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue$1.08B$1.47B$1.97B$2.41B$2.47B$3.95B$3.73B$3.86B$4.00B$4.03B
Revenue growth+27.7%+36.4%+33.5%+22.4%+2.7%+59.9%−5.5%+3.4%+3.5%+0.9%
Gross profit$815.3M$1.12B$1.45B$1.74B$1.76B$2.94B$2.63B$2.71B$2.80B$2.71B
Operating income$248.9M$353.6M$466.6M$542.5M$387.2M$976.4M$642.6M$643.3M$607.6M$545.8M
Net income$189.7M$231.4M$400.2M$442.8M$1.78B$772.0M$361.6M$445.1M$421.4M$410.4M
Diluted EPS$2.33$2.83$4.92$5.53$22.41$9.69$4.61$5.81$5.62$5.65
Gross margin75.5%75.8%73.6%72.5%71.3%74.3%70.5%70.1%70.0%67.2%
Operating margin23.1%24.0%23.7%22.5%15.7%24.7%17.2%16.7%15.2%13.5%
Net margin17.6%15.7%20.4%18.4%71.8%19.5%9.7%11.5%10.5%10.2%

Cash flow

Align Technology cash flow, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Operating cash flow$247.7M$438.5M$554.7M$747.3M$662.2M$1.17B$568.7M$785.8M$738.2M$593.2M
Capital expenditure$70.58M$195.7M$223.3M$149.7M$154.9M$401.1M$291.9M$177.7M$115.6M$102.4M
Free cash flow$177.1M$242.8M$331.4M$597.6M$507.3M$771.4M$276.8M$608.1M$622.7M$490.8M

Balance sheet and shares

Align Technology balance sheet and shares, annual
PeriodFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Cash and equivalents$389.3M$449.5M$636.9M$550.4M$960.8M$1.10B$942.0M$937.4M$1.04B$1.09B
Total debt$0.00$0.00$0.00$59.20M$86.18M$125.4M$126.9M$126.6M$119.3M$114.4M
Shareholders' equity$995.4M$1.15B$1.25B$1.35B$3.23B$3.62B$3.60B$3.63B$3.85B$4.05B
Diluted shares81.5M81.8M81.4M80.1M79.2M79.7M78.4M76.6M75.0M72.6M

Quarterly figures

The last eight fiscal quarters, the latest ending 30 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.

Align Technology quarterly financial figures
PeriodQ4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Revenue$995.2M$979.3M$1.01B$995.7M$1.05B$1.04B$1.06B$1.01B
Revenue, year on year+4.0%−1.8%−1.6%+1.8%+5.3%+6.2%+4.3%+1.9%
Gross margin70.0%69.5%69.9%64.2%65.3%70.8%71.7%68.7%
Operating income$144.1M$131.1M$163.0M$96.30M$155.3M$142.0M$154.0M$169.2M
Net income$103.8M$93.23M$124.6M$56.75M$135.8M$112.8M$108.3M$135.0M
Diluted EPS$1.39$1.27$1.72$0.78$1.89$1.57$1.51$1.90
Free cash flow$263.1M$27.39M$107.2M$169.0M$187.3M$120.3M$157.1M$137.9M

Operating KPIs

The operating figures Align Technology reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.

Align Technology operating KPIs
KPILatestPeriodChange on a yearRecent periods
Clear aligner case volume690.6Kquarter to 30 Sep 2026up 6.6%
Remaining performance obligations$1.3Bat 30 Sep 2026down 9.6%
Clear Aligner revenue$839.3Mquarter to 30 Sep 2026up 4.2%
Systems and Services revenue$175.5Mquarter to 30 Sep 2026down 7.6%

Method

Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.

The same figures as plain text and JSON.

Questions

What was Align Technology's revenue in fiscal 2025?

$4.03 billion for fiscal year 2025 (the twelve months to 31 Dec 2025), as reported in its annual report.

What was Align Technology's net income in fiscal 2025?

$410 million for fiscal year 2025 (the twelve months to 31 Dec 2025).

What were Align Technology's diluted earnings per share in fiscal 2025?

$5.65 for fiscal year 2025 (the twelve months to 31 Dec 2025).

What is Align Technology's gross margin?

67.2% for fiscal year 2025 (the twelve months to 31 Dec 2025): gross profit divided by revenue.

What is Align Technology's operating margin?

13.5% for fiscal year 2025 (the twelve months to 31 Dec 2025): operating income divided by revenue.

How much free cash flow did Align Technology generate in fiscal 2025?

$491 million for fiscal year 2025 (the twelve months to 31 Dec 2025): operating cash flow less capital expenditure.

Where does Align Technology's revenue come from?

In fiscal 2025, by segment: Clear Aligner $3.25B (80%), Systems and Services $789.6M (20%), out of $4.04B in all, as stated in its annual report.

In the terminal

Twenty years of Align Technology's figures, KPIs, guidance and a cash-flow valuation.

  • Every report line and operating figure, quarter by quarter
  • Guidance against what was delivered
  • Insider trades and institutional holders
  • Alerts on results, filings and price
See plans